← FDA Drug Approvals (Drugs@FDA)

MELAMISA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2016-01-26

Drug application

FDA Application #

ANDA202016

Application type

Abbreviated New Drug Application (Generic)

Brand name

MELAMISA

Generic name

Drospirenone

Active ingredients

DROSPIRENONE; ETHINYL ESTRADIOL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVAST LABS

First approval

2016-01-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown